Media coverage
64
Media coverage
Title TD2 To Highlight Development Of A Dual-Specific Inhibitor For Treatment Of Primary Myelofibrosis At ASH Annual Meeting Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 5/12/23 Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet APNews.com Country/Territory United States Date 5/12/23 URL https://apnews.com/press-release/ein-presswire-newsmatics/medication-7a3aa778bf1bcb9bc695993d820e0edd Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet EIN Presswire Country/Territory United States Date 5/12/23 URL https://www.einpresswire.com/article/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WVNS Country/Territory United States Date 5/12/23 URL https://www.wvnstv.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WPHL-TV Country/Territory United States Date 5/12/23 URL https://phl17.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet LocalSRY.com Country/Territory United States Date 5/12/23 URL https://www.localsyr.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet CNYHomepage.com Country/Territory United States Date 5/12/23 URL https://www.cnyhomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Fox40 KTXL Country/Territory United States Date 5/12/23 URL https://fox40.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WJTV.com Country/Territory United States Date 5/12/23 URL https://www.wjtv.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet CBS4Indy Country/Territory United States Date 5/12/23 URL https://cbs4indy.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Big Country Country/Territory United States Date 5/12/23 URL https://www.bigcountryhomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Fox 4 WDAF TV Country/Territory United States Date 5/12/23 URL https://fox4kc.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WRBL-TV Country/Territory Georgia Date 5/12/23 URL https://www.wrbl.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WKRG Country/Territory United States Date 5/12/23 URL https://www.wkrg.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet CW39 NewsFix Country/Territory United States Date 5/12/23 URL https://cw39.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WJET Country/Territory United States Date 5/12/23 URL https://www.yourerie.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WesternSlopeNow.com Country/Territory United States Date 5/12/23 URL https://www.westernslopenow.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WTRF Country/Territory United States Date 5/12/23 URL https://www.wtrf.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WSPA.com Country/Territory United States Date 5/12/23 URL https://www.wspa.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet FOX 31 News KDVR Country/Territory United States Date 5/12/23 URL https://kdvr.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet MyPanhandle.com Country/Territory United States Date 5/12/23 URL https://www.mypanhandle.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WHNT-TV Country/Territory United States Date 5/12/23 URL https://whnt.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Wavy Country/Territory United States Date 5/12/23 URL https://www.wavy.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KELOLAND TV Country/Territory United States Date 5/12/23 URL https://www.keloland.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet INFORMNNY.com Country/Territory United States Date 5/12/23 URL https://www.informnny.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WBOY Country/Territory United States Date 5/12/23 URL https://www.wboy.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WLNS Country/Territory United States Date 5/12/23 URL https://www.wlns.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KODE TV Country/Territory United States Date 5/12/23 URL https://www.fourstateshomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WBTW News13 Country/Territory United States Date 5/12/23 URL https://www.wbtw.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet OurQuadCities.com Country/Territory United States Date 5/12/23 URL https://www.ourquadcities.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WWLP.com Country/Territory United States Date 5/12/23 URL https://www.wwlp.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WETM 18 Country/Territory United States Date 5/12/23 URL https://www.mytwintiers.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Valleycentral.com Country/Territory United States Date 5/12/23 URL https://www.valleycentral.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WTVW FOX 7 Country/Territory United States Date 5/12/23 URL https://www.tristatehomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet MyHighPlains.com Country/Territory United States Date 5/12/23 URL https://www.myhighplains.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WIAT TV Country/Territory United States Date 5/12/23 URL https://www.cbs42.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Binghamton Homepage Country/Territory United States Date 5/12/23 URL https://www.binghamtonhomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet ABC 27 Country/Territory United States Date 5/12/23 URL https://www.abc27.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WYZZ-TV Country/Territory United States Date 5/12/23 URL https://www.centralillinoisproud.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WIProud.com Country/Territory United States Date 5/12/23 URL https://www.wiproud.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Kark.com Country/Territory United States Date 5/12/23 URL https://www.kark.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Fox8 Country/Territory United States Date 5/12/23 URL https://fox8.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet CBS17.com Country/Territory United States Date 5/12/23 URL https://www.cbs17.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WKRN Country/Territory United States Date 5/12/23 URL https://www.wkrn.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WCBD Country/Territory United States Date 5/12/23 URL https://www.counton2.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WeAreGreenBay.com Country/Territory United States Date 5/12/23 URL https://www.wearegreenbay.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet My Champlain Valley Country/Territory United States Date 5/12/23 URL https://www.mychamplainvalley.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WDTN Country/Territory United States Date 5/12/23 URL https://www.wdtn.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WJBF-TV Country/Territory Georgia Date 5/12/23 URL https://www.wjbf.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KNWA Country/Territory United States Date 5/12/23 URL https://www.nwahomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WFXRTV.com Country/Territory United States Date 5/12/23 URL https://www.wfxrtv.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KRQE Country/Territory United States Date 5/12/23 URL https://www.krqe.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Rochesterfirst.com Country/Territory United States Date 5/12/23 URL https://www.rochesterfirst.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet ConchoValleyHomepage.com Country/Territory United States Date 5/12/23 URL https://www.conchovalleyhomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WATE Country/Territory United States Date 5/12/23 URL https://www.wate.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WYOU Country/Territory United States Date 5/12/23 URL https://www.pahomepage.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KETK & FOX51 Country/Territory United States Date 5/12/23 URL https://www.ketk.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KXNet.com Country/Territory United States Date 5/12/23 URL https://www.kxnet.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet KHON 2 Country/Territory United States Date 5/12/23 URL https://www.khon2.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WPRI Country/Territory United States Date 5/12/23 URL https://www.wpri.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WSAV Country/Territory Georgia Date 5/12/23 URL https://www.wsav.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet WCIA.com Country/Territory United States Date 5/12/23 URL https://www.wcia.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet Myarklamiss.com Country/Territory United States Date 5/12/23 URL https://www.myarklamiss.com/business/press-releases/ein-presswire/672853191/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas Title TD2 to Highlight Development of a Dual-Specific Inhibitor for Treatment of Primary Myelofibrosis at ASH Annual Meeting Media name/outlet BusinessFortNight.com Country/Territory India Date 5/12/23 URL https://businessfortnight.com/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis-at-ash-annual-meeting/ Persons Ronald Hoffman, Christoph Schaniel, John Mascarenhas